Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Market News: Novo Nordisk (NVO.US) begins testing low-dose oral Wegovy tablets in a new obesity study.

Market News: Novo Nordisk (NVO.US) begins testing low-dose oral Wegovy tablets in a new obesity study.

智通财经智通财经2026/08/19 07:41
Show original
Market News: Novo Nordisk (NVO.US) has begun testing low-dose oral Wegovy tablets in a new obesity study.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!